CINECA IRIS Institutional Research Information System
IRIS è l'Anagrafe della ricerca dell'Università degli Studi di Trento, e ha lo scopo di raccogliere, documentare, conservare e diffondere, anche ad accesso aperto, la produzione scientifica degli autori afferenti all'Università degli Studi di Trento.
EnglishHalf of human cancers harbor TP53 mutations that render p53 inactive as a tumor suppressor. In these cancers, reactivation of mutant p53 (mutp53) through restoration of wild-type-like function constitutes a valuable anticancer therapeutic strategy. In order to search for mutp53 reactivators, a small library of tryptophanol-derived oxazoloisoindolinones was synthesized and the potential of these compounds as mutp53 reactivators and anticancer agents was investigated in human tumor cells and xenograft mouse models. By analysis of their anti-proliferative effect on a panel of p53-null NCI-H1299 tumor cells ectopically expressing highly prevalent mutp53, the compound SLMP53-2 was selected based on its potential reactivation of multiple structural mutp53. In mutp53-Y220C-expressing hepatocellular carcinoma (HCC) cells, SLMP53-2-induced growth inhibition was mediated by cell cycle arrest, apoptosis, and endoplasmic reticulum stress response. In these cells, SLMP53-2 restored wild-type-like conformation and DNA-binding ability of mutp53-Y220C by enhancing its interaction with the heat shock protein 70 (Hsp70), leading to the reestablishment of p53 transcriptional activity. Additionally, SLMP53-2 displayed synergistic effect with sorafenib, the only approved therapy for advanced HCC. Notably, it exhibited potent antitumor activity in human HCC xenograft mouse models with a favorable toxicological profile. Collectively, SLMP53-2 is a new mutp53-targeting agent with promising antitumor activity, particularly against HCC.
SLMP53-2 Restores Wild-Type-Like Function to Mutant p53 through Hsp70: Promising Activity in Hepatocellular Carcinoma / Gomes, Sara; Bosco, Bartolomeo; Loureiro, Joana B; Ramos, Helena; Raimundo, Liliana; Soares, Joana; Nazareth, Nair; Barcherini, Valentina; Domingues, Lucília; Oliveira, Carla; Bisio, Alessandra; Piazza, Silvano; Bauer, Matthias R; Brás, João P; Almeida, Maria Inês; Gomes, Célia; Reis, Flávio; Fersht, Alan R; Inga, Alberto; Santos, Maria M M; Saraiva, Lucília. - In: CANCERS. - ISSN 2072-6694. - 11:8(2019), p. 1151. [10.3390/cancers11081151]
| Titolo: | SLMP53-2 Restores Wild-Type-Like Function to Mutant p53 through Hsp70: Promising Activity in Hepatocellular Carcinoma | |
| Autori: | Gomes, Sara; Bosco, Bartolomeo; Loureiro, Joana B; Ramos, Helena; Raimundo, Liliana; Soares, Joana; Nazareth, Nair; Barcherini, Valentina; Domingues, Lucília; Oliveira, Carla; Bisio, Alessandra; Piazza, Silvano; Bauer, Matthias R; Brás, João P; Almeida, Maria Inês; Gomes, Célia; Reis, Flávio; Fersht, Alan R; Inga, Alberto; Santos, Maria M M; Saraiva, Lucília | |
| Autori Unitn: | ||
| Titolo del periodico: | CANCERS | |
| Anno di pubblicazione: | 2019 | |
| Numero e parte del fascicolo: | 8 | |
| Codice identificativo Scopus: | 2-s2.0-85073295665 | |
| Codice identificativo Pubmed: | 31405179 | |
| Codice identificativo WOS: | WOS:000484438000111 | |
| Digital Object Identifier (DOI): | http://dx.doi.org/10.3390/cancers11081151 | |
| Handle: | http://hdl.handle.net/11572/241142 | |
| Citazione: | SLMP53-2 Restores Wild-Type-Like Function to Mutant p53 through Hsp70: Promising Activity in Hepatocellular Carcinoma / Gomes, Sara; Bosco, Bartolomeo; Loureiro, Joana B; Ramos, Helena; Raimundo, Liliana; Soares, Joana; Nazareth, Nair; Barcherini, Valentina; Domingues, Lucília; Oliveira, Carla; Bisio, Alessandra; Piazza, Silvano; Bauer, Matthias R; Brás, João P; Almeida, Maria Inês; Gomes, Célia; Reis, Flávio; Fersht, Alan R; Inga, Alberto; Santos, Maria M M; Saraiva, Lucília. - In: CANCERS. - ISSN 2072-6694. - 11:8(2019), p. 1151. [10.3390/cancers11081151] | |
| Appare nelle tipologie: | 03.1 Articolo su rivista (Journal article) |
File in questo prodotto:
| File | Descrizione | Tipologia | Licenza | |
|---|---|---|---|---|
| cancers-11-01151.pdf | Versione editoriale (Publisher’s layout) |  | Open Access Visualizza/Apri |
Copyright © 2022